This antibody selectively binds to all active forms of uPA but not inactive forms. It selectively inhibits the active form of the protease urokinase plasminogen activator (uPA, PLAU) and can be potentially used in the treatment of prostate cancer.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.